Posaconazole CAS NO: 171228-49-2

Product Description:

Product Name: Posaconazole CAS NO: 171228-49-2

Synonyms:

4-[4-[4-[4-[[(3R,5R)-5-(2,4-Difluorophenyl)-5-(1,2,4-triazol-1-ylmethyl)oxolan-3-yl]metho xy]phenyl]piperazin-1-yl]phenyl]-2-[(2S,3S)-2-hydroxypentan-3-yl]-1,2,4-triazol-3-one;

Chemical & Physical Properties:

Appearance : White solid

Assay :≥99.0%

Density: 1.36g/cm3

Boiling Point: 850.7℃ at 760 mmHg

Flash Point:468.3℃

Melting Point:170-172℃

Posaconazole (posaconazole) is derived from itraconazole. Its pharmacological effects are similar with azoles, but compared with itraconazole, it has a stronger inhibitory effect on the C14 demethylation of stero id, especially for Aspergillus.

It can be clinically used for the treatment of aspergillosis, zygnmycosis, and fusariumsis and can also be used for infection caused by part of fluconazole-resistant Candida genus. Studies have shown that posaconazole can widely and effectively applied to the treatment of phaeohyphomycosis and improve the infection survival rate of dermatitidis infection in a dose-dependent manner.

If you are interested in our products or have any questions, please feel free to contact us!

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.